HIV-1特异性细胞毒性T淋巴细胞与HIV-1复制的控制 - Suppr

Suppr

超能文献

HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.

作者信息

Jassoy C, Walker B D

机构信息

Institute for Virology and Immunobiology, Julius-Maximilians University, Würzburg, Germany.

出版信息

Springer Semin Immunopathol. 1997;18(3):341-54. doi: 10.1007/BF00813502.

DOI:10.1007/BF00813502

PMID:9089953

Abstract

摘要

相似文献

HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.

Springer Semin Immunopathol. 1997;18(3):341-54. doi: 10.1007/BF00813502.

Cellular immune responses to HIV-1 in progressive and non-progressive infections.

AIDS. 1996;10 Suppl A:S85-96. doi: 10.1097/00002030-199601001-00013.

Immune control of HIV-1 replication.

Adv Exp Med Biol. 1998;452:159-67. doi: 10.1007/978-1-4615-5355-7_17.

Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.

AIDS Res Hum Retroviruses. 1999 Feb 10;15(3):223-7. doi: 10.1089/088922299311394.

Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.

Viral Immunol. 2003;16(3):381-93. doi: 10.1089/088282403322396172.

CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.

Adv Immunol. 1997;66:273-311. doi: 10.1016/s0065-2776(08)60600-8.

Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.

Cell Mol Biol (Noisy-le-grand). 1994;40 Suppl 1:45-8.

The moving target: mechanisms of HIV persistence during primary infection.

Immunol Today. 1999 Oct;20(10):446-50. doi: 10.1016/s0167-5699(99)01504-2.

HIV-1 evolution and disease progression.

Science. 1996 Nov 8;274(5289):1008-11. doi: 10.1126/science.274.5289.1008.

Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Springer Semin Immunopathol. 1997;18(3):371-90. doi: 10.1007/BF00813504.

引用本文的文献

Novel mouse models for understanding HIV-1 pathogenesis.

Methods Mol Biol. 2009;485:311-27. doi: 10.1007/978-1-59745-170-3_21.

Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):149-55. doi: 10.1097/QAI.0b013e31816d9c3b.

Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.

J Virol. 2008 Mar;82(6):3078-89. doi: 10.1128/JVI.01812-07. Epub 2008 Jan 9.

The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.

Pathol Oncol Res. 1997;3(1):62-67. doi: 10.1007/BF02893356.

Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Microbiol Mol Biol Rev. 2000 Dec;64(4):725-45. doi: 10.1128/MMBR.64.4.725-745.2000.

Virus and target cell evolution in human immunodeficiency virus type 1 infection.

Immunol Res. 2000;21(2-3):253-8. doi: 10.1385/IR:21:2-3:253.

Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2725-30. doi: 10.1073/pnas.040575197.

Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

J Virol. 1999 Jun;73(6):4829-39. doi: 10.1128/JVI.73.6.4829-4839.1999.

Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

J Virol. 1999 Apr;73(4):3292-300. doi: 10.1128/JVI.73.4.3292-3300.1999.

Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?

Immunol Rev. 1998 Aug;164(1):37-51. doi: 10.1111/j.1600-065x.1998.tb01206.x.

本文引用的文献

T lymphocytes and their cytokines in human immunodeficiency virus (HIV) infection: implications for associated neoplasias.

Crit Rev Oncog. 1995;6(3-6):275-89. doi: 10.1615/critrevoncog.v6.i3-6.50.

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.

Immunol Today. 1996 May;17(5):217-24. doi: 10.1016/0167-5699(96)10011-6.

Neuropathology of early HIV-1 infection.

Brain Pathol. 1996 Jan;6(1):1-15. doi: 10.1111/j.1750-3639.1996.tb00775.x.

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

J Immunol. 1996 Apr 1;156(7):2616-23.

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585.

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

J Virol. 1996 Sep;70(9):5799-806. doi: 10.1128/JVI.70.9.5799-5806.1996.

Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation.

J Immunol. 1996 Jun 1;156(11):4476-83.

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Science. 1996 Jun 28;272(5270):1955-8. doi: 10.1126/science.272.5270.1955.

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Science. 1996 May 24;272(5265):1167-70. doi: 10.1126/science.272.5265.1167.

HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Science. 1996 May 10;272(5263):872-7. doi: 10.1126/science.272.5263.872.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验